Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Non Operating Income (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Non Operating Income data on record, last reported at -$3.8 million in Q3 2025.

  • For Q3 2025, Non Operating Income fell 33990.91% year-over-year to -$3.8 million; the TTM value through Sep 2025 reached $759000.0, down 89.57%, while the annual FY2024 figure was $153000.0, 98.36% down from the prior year.
  • Non Operating Income reached -$3.8 million in Q3 2025 per SNTI's latest filing, down from $4.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $10.6 million in Q3 2022 and bottomed at -$3.8 million in Q3 2025.
  • Average Non Operating Income over 5 years is $1.4 million, with a median of $22500.0 recorded in 2021.
  • The widest YoY moves for Non Operating Income: up 69066.67% in 2025, down 33990.91% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $21000.0 in 2021, then surged by 8500.0% to $1.8 million in 2022, then soared by 303.38% to $7.3 million in 2023, then tumbled by 97.82% to $159000.0 in 2024, then tumbled by 2458.49% to -$3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$3.8 million in Q3 2025, $4.1 million in Q2 2025, and $200000.0 in Q1 2025.